BioCryst Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.88 billion, with shareholders equity totaling $-397.38 million.
The company employs approximately 246 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, BioCryst Pharmaceuticals Inc. reported $961.51 million in revenue, generating net income of $-359.66 million.
Key financial metrics include a P/E ratio of -5.23, a price-to-book (P/B) ratio of -4.74, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker BCRX.